SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-21-012652
Filing Date
2021-05-24
Accepted
2021-05-24 13:38:32
Documents
55
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 724223
2 ex31-1.htm EX-31.1 11719
3 ex31-2.htm EX-31.2 11836
4 ex32-1.htm EX-32.1 5080
5 ex32-2.htm EX-32.2 5000
6 form10-q_001.jpg GRAPHIC 22914
7 form10-q_002.jpg GRAPHIC 14193
  Complete submission text file 0001493152-21-012652.txt   3821123

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE FILE rspi-20210331.xml EX-101.INS 602520
9 XBRL SCHEMA FILE rspi-20210331.xsd EX-101.SCH 43319
10 XBRL CALCULATION FILE rspi-20210331_cal.xml EX-101.CAL 39649
11 XBRL DEFINITION FILE rspi-20210331_def.xml EX-101.DEF 207349
12 XBRL LABEL FILE rspi-20210331_lab.xml EX-101.LAB 306386
13 XBRL PRESENTATION FILE rspi-20210331_pre.xml EX-101.PRE 253978
Mailing Address 126 VALLEY ROAD SUITE C GLEN ROCK NJ 07452
Business Address 126 VALLEY ROAD SUITE C GLEN ROCK NJ 07452 (201) 444-4947
RespireRx Pharmaceuticals Inc. (Filer) CIK: 0000849636 (see all company filings)

IRS No.: 330303583 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-16467 | Film No.: 21953144
SIC: 2834 Pharmaceutical Preparations